aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析

◆英語タイトル:aTyr Pharma Inc (LIFE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15073
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to the neuropilin-2 receptor harness immune engagement in interstitial lung diseases and other immune-mediated diseases. It also concentrates on research and development of extracellular functionality of tRNA synthetases. ATyr Pharma also develops drugs for cancer, inflammation, neurodegenerative diseases, and metabolic disorders. The company collaborates with research institutions for its research and development activities. ATyr Pharma is headquartered in San Diego, California, the US.

aTyr Pharma Inc Key Recent Developments

Nov 13,2018: aTyr Pharma announces third quarter 2018 operating results
Oct 17,2018: aTyr Pharma Presents at American Society of Human Genetics 2018 Meeting
Oct 15,2018: aTyr Pharma announces leadership transition
Sep 27,2018: aTyr Pharma Announces Pulmonary Sarcoidosis as Disease Indication for Phase 1b/2a Clinical Study and Educational Webinar

This comprehensive SWOT profile of aTyr Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of aTyr Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

aTyr Pharma Inc – Key Information
aTyr Pharma Inc – Overview
aTyr Pharma Inc – Key Employees
aTyr Pharma Inc – Key Employee Biographies
aTyr Pharma Inc – Key Operational Heads
aTyr Pharma Inc – Major Products and Services
aTyr Pharma Inc – History
aTyr Pharma Inc – Company Statement
aTyr Pharma Inc – Locations And Subsidiaries
aTyr Pharma Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

aTyr Pharma Inc – Business Description
aTyr Pharma Inc – Corporate Strategy
aTyr Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
aTyr Pharma Inc – Strengths
aTyr Pharma Inc – Weaknesses
aTyr Pharma Inc – Opportunities
aTyr Pharma Inc – Threats
aTyr Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

aTyr Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

aTyr Pharma Inc, Key Information
aTyr Pharma Inc, Key Ratios
aTyr Pharma Inc, Share Data
aTyr Pharma Inc, Major Products and Services
aTyr Pharma Inc, History
aTyr Pharma Inc, Key Employees
aTyr Pharma Inc, Key Employee Biographies
aTyr Pharma Inc, Key Operational Heads
aTyr Pharma Inc, Other Locations
aTyr Pharma Inc, Subsidiaries
aTyr Pharma Inc, Key Manufacturing facilities
aTyr Pharma Inc, Key Competitors
aTyr Pharma Inc, SWOT Analysis
aTyr Pharma Inc, Ratios based on current share price
aTyr Pharma Inc, Annual Ratios
aTyr Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

aTyr Pharma Inc, Performance Chart
aTyr Pharma Inc, Ratio Charts

★海外企業調査レポート[aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Varta Microbattery GmbH:企業の戦略的SWOT分析
    Varta Microbattery GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Mologic Ltd-医療機器分野:企業M&A・提携分析
    Summary Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and markets in vitro diagnostic medical devices. The company’s products include bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit. Its experti …
  • Legg Mason Inc:企業の戦略・SWOT・財務情報
    Legg Mason Inc - Strategy, SWOT and Corporate Finance Report Summary Legg Mason Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Guodian United Power Technology Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Guodian United Power Technology Co Ltd (United Power), a subsidiary of China Guodian Corp, is a wind turbine equipment manufacturing company that concentrates on green energy industry. The company provides wind turbine generator systems. It provides product portfolio such as wind turbine ser …
  • China Huaneng Group Co Ltd:企業の戦略的SWOT分析
    China Huaneng Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Zirax Ltd:企業の戦略的SWOT分析
    Zirax Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Sohu.com Inc. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Inc. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mitek Systems Inc (MITK):企業の財務・戦略的SWOT分析
    Summary Mitek Systems Inc (Mitek) is a technology company that develops and markets payment and fraud prevention software products. The company offers products such as Mobile Verify, Mobile Docs, Mobile Fill, Mobile Deposit and Multi Check Capture. Its Mobile Verify is a Mitek's ID verification solu …
  • Sibanye Gold Ltd:企業の戦略・SWOT・財務情報
    Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • European Medical Contract Manufacturing BV:医療機器:M&Aディール及び事業提携情報
    Summary European Medical Contract Manufacturing BV (EMCM BV), a subsidiary of Leader Biomedical Group, is a developer and manufacturer of sterile medicinal products. The company’s products include bone cements for hip and knee arthroplasty and vertebroplasty procedures; cement restrictors; human bon …
  • Intracom Holdings S.A. (INTRK):企業の財務・戦略的SWOT分析
    Intracom Holdings S.A. (INTRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • The Netherlands Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • Jamba, Inc.:企業の戦略・SWOT・財務分析
    Jamba, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jamba, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析
    Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Egyptian Resorts Co
    Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report Summary Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sampo plc:企業のM&A・事業提携・投資動向
    Sampo plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sampo plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Altana AG:企業の戦略的SWOT分析
    Altana AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Fubon Financial Holding Co Ltd:戦略・SWOT・企業財務分析
    Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hindustan Construction Co. Ltd (HCC):企業の財務・戦略的SWOT分析
    Hindustan Construction Co. Ltd (HCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆